GREENBROOK TMS RAISES US$2.5 MILLION IN DEBT FINANCING
TORONTO, Feb. 15, 2024 /PRNewswire/ - Greenbrook TMS Inc. today announced that it has entered into the twenty-fifth amendment to the Company's credit facility with affiliates of Madryn Asset...
Stay updated with breaking news from Neuronetics Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
TORONTO, Feb. 15, 2024 /PRNewswire/ - Greenbrook TMS Inc. today announced that it has entered into the twenty-fifth amendment to the Company's credit facility with affiliates of Madryn Asset...
/PRNewswire/ - Greenbrook TMS Inc. (NASDAQ: GBNH) ("Greenbrook" or the "Company") today announced that it has entered into the twenty-fifth amendment (the...
/PRNewswire/ -- The "Neuromodulation Devices Market Report 2024-2034" has been added to ResearchAndMarkets.com's offering. Revenue for the neuromodulation...
Criteria Change Reduces Requirements for Treatment AccessibilityMALVERN, Pa., Feb. 06, 2024 -- Neuronetics, Inc. , a medical technology company focused on designing, developing, and marketing...
/PRNewswire/ - Greenbrook TMS Inc. (NASDAQ: GBNH) ("Greenbrook" or the "Company") today announced that it has entered into the twenty-fourth amendment (the...